Description
IBM Financial Transaction Manager 3.2.0 through 3.2.8 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 192952.
Published: 2021-06-15
Score: 5.4 Medium
EPSS: < 1% Very Low
KEV: No
Impact: n/a
Action: n/a
AI Analysis

No analysis available yet.

Remediation

No remediation available yet.

Tracking

Sign in to view the affected projects.

Advisories
Source ID Title
EUVD EUVD EUVD-2020-26247 IBM Financial Transaction Manager 3.2.0 through 3.2.8 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 192952.
History

Tue, 17 Sep 2024 01:30:00 +0000

Type Values Removed Values Added
Description IBM Financial Transaction Manager 3.2.0 through 3.2.8 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 192952. IBM Financial Transaction Manager 3.2.0 through 3.2.8 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 192952.

Subscriptions

Ibm Financial Transaction Manager
cve-icon MITRE

Status: PUBLISHED

Assigner: ibm

Published:

Updated: 2024-09-17T01:25:38.641Z

Reserved: 2019-12-30T00:00:00.000Z

Link: CVE-2020-5000

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Modified

Published: 2021-06-15T20:15:11.433

Modified: 2024-11-21T05:33:31.980

Link: CVE-2020-5000

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses